Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1 1
    Belgium Bulgaria Czechia Denmark Finland France +10
  • Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Bulgaria Croatia Czechia Denmark +12
  • Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

    Not recruiting

    4 1
    Investigated drugs:
    Belgium France Germany Greece Italy The Netherlands +1
  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments

    Not recruiting

    3 1 1
    Investigated drugs:
    Bulgaria Czechia Denmark Germany Hungary Poland +1
  • Study on the Effectiveness and Safety of Finerenone for Patients with Chronic Kidney Disease and Type 1 Diabetes

    Not recruiting

    3 1
    Investigated drugs:
    Denmark Germany Italy Spain
  • Study of CVN424 for Reducing Motor Complications in Parkinson’s Disease Patients

    Not recruiting

    2 1
    Investigated diseases:
    Czechia France Italy Poland Spain
  • Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

    Not recruiting

    3 1
    Investigated drugs:
    Austria Finland Germany Hungary Italy The Netherlands +4
  • Study on the Long-term Safety of Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1
    Investigated drugs:
    Belgium Bulgaria Denmark Germany Greece Italy +4
  • Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

    Not recruiting

    2 1 1
    Investigated drugs:
    Belgium Denmark France Italy Spain
  • Study on the Safety and Effects of ALN-APP for Patients with Cerebral Amyloid Angiopathy

    Not recruiting

    2 1
    Investigated drugs:
    The Netherlands